Trends of demographic and clinical traits of young patients with breast cancer from the National Cancer Database: Disproportionate effect on underrepresented underserved populations.

Cynthia Mark,Vivek Pujara,Marissa K. Boyle,Yuan Yuan,Jin Sun Bitar
DOI: https://doi.org/10.1200/jco.2024.42.16_suppl.e13715
IF: 45.3
2024-05-31
Journal of Clinical Oncology
Abstract:e13715 Background: Over the past decade, there has been increasing incidence of young patients diagnosed with cancer. Despite these developments, there is still uncertainty surrounding the factors and patterns contributing to the rising incidence in young age. This study aims to explore the demographic and clinical characteristics of young breast cancer (YBC) patients. Methods: We obtained characteristics and survival data from 206,156 of young patients (≤ 40 years of age) diagnosed with breast cancer between 2005 and 2019 in the National Cancer Database (NCDB). The demographic and clinical data were subdivided the patients into two comparison groups based on year of diagnosis with 10 years interval (2005-2009, Old vs. 2015-2019, New group). The z-score test was employed to measure the changes in the 2 groups. Cox proportional hazards model was used to explore the variables influencing overall survival (OS). Results: Overall, the absolute number of YBC patients have been increasing every year. The comparison between Old (55397 pt) and New groups (67930 pt) showed increase in Hispanic (4,575 (8.3%) vs 6,720 (9.9%), p <0.0001), Black (8,695 (15.7%) vs 11,156 (16.4%), p=0.0005), Asian (2,592 (4.7%) vs 4,512 (6.6%), p<0.0001), and other minority populations. Non-Hispanic White showed no change (p=0.1902). Additionally, there was a reduction in the proportion of patients with private insurance (43,940 (79.3%) vs 51,104 (75.2%), p<0.0001) and an increase in patients with Medicaid (5,893 (10.6%) vs 10,694 (15.7%), p<0.0001). Interestingly, there was a significant increase in hormone positive disease (35,142 (63.4%) vs 49,409 (72.7%), p<0.0001), while no change in hormone negative disease. In New group, the influence of race is evident in the observed variations in OS (Table). Finally, patients with Medicaid or without insurance exhibited a diminished OS compared to those with private insurance, and a lower median income was associated with a negative impact on OS. Conclusions: For YBC patients, the proportion of underrepresented and underserved population is increasing. There is an increasing rate of hormone positive disease. This can cause substantial personal and societal implications, such as family planning and early menopause. Therefore, awareness of these at-risk populations is important for early identification of breast cancer and mitigation of poorer outcomes. [Table: see text]
oncology
What problem does this paper attempt to address?